TOKYO, Oct 16, 2024 - (JCN Newswire) - - Eisai Co., Ltd. announced today that amyotrophic lateral sclerosis (ALS) treatment "Rozebalamin(R) for Injection 25 mg" (mecobalamin) has received the Good ...
Learn about Amyotrophic Lateral Sclerosis (ALS), its symptoms, risk factors, diagnosis, and current research advancements.
NEW YORK, July 10, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO), a gene and cell therapy company focused on the treatment of neurodegenerative and other aging-related diseases, today ...
Amyotrophic lateral sclerosis (ALS) affects the nerve cells in the brain and spinal cord that control muscle movement. Different types of ALS cause symptoms to begin in a certain part of the body and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback